佛罗里达州坦帕--(BUSINESS WIRE)--(美国商业资讯)-- 创新药物递送技术领域的全球先驱企业Concept Medical Inc.自豪地宣布，STARS DAPT随机对照试验已成功完成首例患者入组。该试验全称为ST段抬高型心肌梗死患者接受无聚合物西罗莫司纳米载体洗脱支架治疗，且在短期双 ...

SAN FRANCISCO — Stopping aspirin within 1 month of implanting a drug-eluting stent (DES) for acute coronary syndrome (ACS) followed by ticagrelor monotherapy was shown to be noninferior to 12 months ...

A research team led by Professors Joo-Yong Hahn, Young Bin Song, and Ki Hong Choi of the Division of Cardiology at Samsung ...

DALLAS -- Dual antiplatelet therapy (DAPT) proved non-inferior to IV alteplase in Chinese patients with minor non-disabling stroke, a researcher reported. In the ARAMIS trial of patients with acute ...

Noninferiority was not demonstrated for death and ischemic events between P2Y12 inhibitor monotherapy and dual antiplatelet therapy (DAPT) given for 12 months after stenting in patients with acute ...

While dual antiplatelet therapy (DAPT) has long been the standard of care for the management of acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI), there is an ...

Despite evidence that starting two blood-thinning medications shortly after a minor stroke or a warning stroke (transient ischemic attack - TIA) may prevent a second – possibly more serious – ...

The efficacy of P2Y12 monotherapy depends on the type of drug used after discontinuation of dual antiplatelet therapy (DAPT) for post-PCI patients, according to a new patient-level meta-analysis.

Please provide your email address to receive an email when new articles are posted on . For adults who undergo PCI with a drug-eluting stent, recommendations for dual antiplatelet therapy have evolved ...

Please provide your email address to receive an email when new articles are posted on . In patients with ACS who had angioplasty and stenting, ticagrelor monotherapy after 1 month reduced bleeding vs.